Magnetic targeting strategies in gene delivery

Nanomedicine

Volumn 6, Issue 9, 2011, Pages 1593-1604

  Delyagina, Evgenya ^a   Li, Wenzhong ^a   Ma, Nan ^a   Steinhoff, Gustav ^a  

^a UNIVERSITY OF ROSTOCK   (Germany)

Author keywords

cationic lipid; cationic polymer; magnetic nanoparticles; magnetic targeting; polyethylenimine; targeted gene delivery; transduction

Indexed keywords

ADENOVIRUS VECTOR; ADIPONECTIN; BETA GALACTOSIDASE; ENHANCED GREEN FLUORESCENT PROTEIN; GREEN FLUORESCENT PROTEIN; LENTIVIRUS VECTOR; LIPID; LIPOFECTAMINE; LUCIFERASE; PARVOVIRUS VECTOR; POLYETHYLENEIMINE; PROTEIN BCL 2; RED FLUORESCENT PROTEIN; VASCULOTROPIN;

DRUG SELECTIVITY; GENE DELIVERY SYSTEM; GENE EXPRESSION; GENE INSERTION; GENE TRANSFER; GENE VECTOR; HUMAN; IN VIVO STUDY; LIPOSOMAL DELIVERY; MAGNETISM; NONHUMAN; NONVIRAL GENE DELIVERY SYSTEM; PRIORITY JOURNAL; REVIEW; STEM CELL; TRANSGENE; VIRAL GENE DELIVERY SYSTEM;

ANIMALS; GENE TRANSFER TECHNIQUES; GENETIC VECTORS; HUMANS; MAGNETICS;

EID: 81255195788     PISSN: 17435889     EISSN: 17486963     Source Type: Journal    
DOI: 10.2217/nnm.11.143     Document Type: Review

References (89)

1. Friedmann T. A brief history of gene therapy. Nat. Genet. 2(2), 93-98 (1992).
2. Anderson WF. Human gene therapy. Science 256(5058), 808-813 (1992).
3. Schmidt-Wolf GD, Schmidt-Wolf IG. Bone marrow and clinical gene therapy. J. Hematother. 4(6), 551-561 (1995).
4. Wang W, Li W, Ong LL et al. Localized and sustained SDF-1 gene release mediated by fibronectin films. A potential method for recruiting stem cells. Int. J. Artif. Organs 32(3), 141-149 (2009).
5. Wang W, Li W, Ong LL et al. Localized SDF-1a-gene release mediated by collagen substrate induces CD117 stem cells homing. J. Cell. Mol. Med. 14(1-2), 392-402 (2010).
6. Boulaiz H, Marchal JA, Prados J, Melguizo C, Aranega A. Nonviral and viral vectors for gene therapy. Cell. Mol. Biol. (Noisy-le-grand) 51(1), 3-22 (2005).
7. Ragusa A, Garcia I, Penades S. Nanoparticles as nonviral gene delivery vectors. IEEE Trans. Nanobioscience 6(4), 319-330 (2007).
8. Mintzer MA, Simanek EE. Nonviral vectors for gene delivery. Chem. Rev. 109(2), 259-302 (2009).
9. Al-Dosari MS, Gao X. Nonviral gene delivery. Principle, limitations, and recent progress. AAPS J. 11(4), 671-681 (2009).
10. Gao Y, Liu X, Li X. Reasearch progress on siRNA delivery with nonviral vectors. Int. J. Nanomedicine 6, 1017-1025 (2011).
11. Wells DJ. Gene therapy progress and prospects. Electroporation and other physical methods. Gene Ther. 11(18), 1363-1369 (2004).
12. Boeckle S, Wagner E. Optimizing targeted gene delivery. Chemical modification of viral vectors and synthesis of artificial virus vector systems. AAPS J. 8(4), E731-E742 (2006).
13. Dobson J. Magnetic micro- and nano-particle-based targeting for drug and gene delivery. Nanomedicine (Lond.) 1(1), 31-37 (2006).
14. Sundaram S, Trivedi R, Durairaj C, Ramesh R, Ambati BK, Kompella UB. Targeted drug and gene delivery systems for lung cancer therapy. Clin. Cancer Res. 15(23), 7299-7308 (2009).
15. Patil YB, Swaminathan SK, Sadhukha T, Ma L, Panyam J. The use of nanoparticle-mediated targeted gene silencing and drug delivery to overcome tumor drug resistance. Biomaterials 31(2), 358-365 (2009).
16. Rivest V, Phivilay A, Julien C et al. Novel liposomal formulation for targeted gene delivery. Pharm. Res. 24(5), 981-990 (2007).
17. Cartier R, Reszka R. Utilization of synthetic peptides containing nuclear localization signals for nonviral gene transfer systems. Gene Ther. 9(3), 157-167 (2002).
18. Chan CK, Jans DA. Using nuclear targeting signals to enhance nonviral gene transfer. Immunol. Cell Biol. 80(2), 119-130 (2002).
19. Peng XH, Qian X, Mao H et al. Targeted magnetic iron oxide nanoparticles for tumor imaging and therapy. Int. J. Nanomedicine 3(3), 311-321 (2008).
20. Marek R, Caruso M, Rostami A, Grinspan JB, Das Sarma J. Magnetic cell sorting. A fast and effective method of concurrent isolation of high purity viable astrocytes and microglia from neonatal mouse brain tissue. J. Neurosci. Methods 175(1), 108-118 (2008).
21. +-particles. Methods Mol. Biol. 498, 129-141 (2009).
22. Akiyama H, Ito A, Kawabe Y, Kamihira M. Fabrication of complex three-dimensional tissue architectures using a magnetic force-based cell patterning technique. Biomed. Microdevices 11(4), 713-721 (2009).
23. Srinivas M, Aarntzen EH, Bulte JW et al. Imaging of cellular therapies. Adv. Drug Deliv. Rev. 62(11), 1080-1093 (2010).
24. Josephson L, Chen SL, Reynolds F, Yu LT, Weissleder R. A screening paradigm for the design of improved polymer-coated superparamagnetic iron oxide nanoparticles. J. Mater. Chem. 19(35), 6387-6392 (2009).
25. Corchero JL, Villaverde A. Biomedical applications of distally controlled magnetic nanoparticles. Trends Biotechnol. 27(8), 468-476 (2009).
26. Mcbain SC, Yiu HH, Dobson J. Magnetic nanoparticles for gene and drug delivery. Int. J. Nanomedicine 3(2), 169-180 (2008).
27. Gupta PK, Hung CT. Magnetically controlled targeted micro-carrier systems. Life Sci. 44(3), 175-186 (1989).
28. Hassan EE, Gallo JM. Targeting anticancer drugs to the brain. I: Enhanced brain delivery of oxantrazole following administration in magnetic cationic microspheres. J. Drug Target. 1(1), 7-14 (1993).
29. Mah C, Fraites TJ Jr., Zolotukhin I et al. Improved method of recombinant AAV2 delivery for systemic targeted gene therapy. Mol. Ther. 6(1), 106-112 (2002).
30. Scherer F, Anton M, Schillinger U et al. Magnetofection: enhancing and targeting gene delivery by magnetic force in vitro and in vivo. Gene Ther. 9(2), 102-109 (2002).
31. Mykhaylyk O, Antequera YS, Vlaskou D, Plank C. Generation of magnetic nonviral gene transfer agents and magnetofection in vitro. Nat. Protoc. 2(10), 2391-2411 (2007).
32. Huth S, Lausier J, Gersting SW et al. Insights into the mechanism of magnetofection using PEI-based magnetofectins for gene transfer. J. Gene Med. 6(8), 923-936 (2004).
33. Sauer AM, de Bruin KG, Ruthardt N, Mykhaylyk O, Plank C, Brauchle C. Dynamics of magnetic lipoplexes studied by single particle tracking in living cells. J. Control Release 137(2), 136-145 (2009).
34. Dobson J. Gene therapy progress and prospects. magnetic nanoparticle-based gene delivery. Gene Ther. 13(4), 283-287 (2006).
35. Weber W, Lienhart C, Daoud-EL Baba M et al. Magnet-guided transduction of mammalian cells and mice using engineered magnetic lentiviral particles. J. Biotechnol. 141(3-4), 118-122 (2009).
36. Pandori M, Hobson D, Sano T. Adenovirus-microbead conjugates possess enhanced infectivity: a new strategy for localized gene delivery. Virology 299(2), 204-212 (2002).
37. Hofmann A, Wenzel D, Becher UM et al. Combined targeting of lentiviral vectors and positioning of transduced cells by magnetic nanoparticles. Proc. Natl Acad. Sci. USA 106(1), 44-49 (2009).
38. Orlando C, Castellani S, Mykhaylyk O et al. Magnetically guided lentiviral-mediated transduction of airway epithelial cells. J. Gene Med. 12(9), 747-754 (2010).
39. Chorny M, Fishbein I, Alferiev I, Levy RJ. Magnetically responsive biodegradable nanoparticles enhance adenoviral gene transfer in cultured smooth muscle and endothelial cells. Mol. Pharm. 6(5), 1380-1387 (2009).
40. Chorny M, Fishbein I, Levy RJ. Uniform-field induced magnetization enables efficient targeting of adenovirus-impregnated magnetic nanoparticles to stented arteries in the rat carotid model of restenosis. Circulation 120(18), S594-S594 (2009).
41. Fishbein I, Chorny M, Levy RJ. Site-specific gene therapy for cardiovascular disease. Curr. Opin. Drug Discov. Devel. 13(2), 203-213 (2011).
42. Boussif O, Lezoualc'h F, Zanta MA et al. A versatile vector for gene and oligonucleotide transfer into cells in culture and in vivo. polyethylenimine. Proc. Natl Acad. Sci. USA 92(16), 7297-7301 (1995).
43. Li W, Ma N, Ong LL et al. Bcl-2 engineered MSCs inhibited apoptosis and improved heart function. Stem Cells 25(8), 2118-2127 (2007).
44. Wang W, Li W, Ou L et al. Polyethylenimine-mediated gene delivery into human bone marrow mesenchymal stem cells from patients. J. Cell. Mol. Med. 15(9), 1989-1998 (2010).
45. Godbey WT, Wu KK, Mikos AG. Size matters: molecular weight affects the efficiency of poly(ethylenimine) as a gene delivery vehicle. J. Biomed. Mater. Res. 45(3), 268-275 (1999).
46. Delyagina E, Li W, Schade A, Kuhlo A-L, Ma N, Steinhoff G. Low molecular weight polyethyleneimine conjugated to magnetic nanoparticles as a vector for gene delivery. AIP Conference Proceedings 1311(1), 479-484 (2010).
47. Mcbain SC, Yiu HHP, El Haj A, Dobson J. Polyethyleneimine functionalized iron oxide nanoparticles as agents for DNA delivery and transfection. J. Mater. Chem. 17(24), 2561-2565 (2007).
48. Levy RJ, Chorny M, Polyak B, Alferiev IS, Walsh K, Friedman G. Magnetically driven plasmid DNA delivery with biodegradable polymeric nanoparticles. FASEB J. 21(10), 2510-2519 (2007).
49. Li W, Ma N, Ong LL et al. Enhanced thoracic gene delivery by magnetic nanobead-mediated vector. J. Gene Med. 10(8), 897-909 (2008).
50. Li WZ, Nesselmann C, Zhou ZH et al. Gene delivery to the heart by magnetic nanobeads. J. Magn. Magn. Mater. 311(1), 336-341 (2007).
51. Emmrich S, Wang W, John K, Li W, Putzer BM. Antisense gapmers selectively suppress individual oncogenic p73 splice isoforms and inhibit tumor growth in vivo. Mol. Cancer 8, 61 (2009).
52. Arsianti M, Lim M, Marquis CP, Amal R. Assembly of polyethylenimine-based magnetic iron oxide vectors: insights into gene delivery. Langmuir 26(10), 7314-7326 (2010).
53. Arsianti M, Lim M, Marquis CP, Amal R. Polyethylenimine based magnetic iron-oxide vector. The effect of vector component assembly on cellular entry mechanism, intracellular localization, and cellular viability. Biomacromolecules 11(9), 2521-2531 (2010).
54. Kamau SW, Hassa PO, Steitz B et al. Enhancement of the efficiency of non-viral gene delivery by application of pulsed magnetic field. Nucleic Acids Res. 34(5), e40 (2006).
55. Lee WC, Chen CB, Chen JY. Fast transfection of mammalian cells using superparamagnetic nanoparticles under strong magnetic field. J. Nanosci. Nanotechnol. 9(4), 2651-2659 (2009).
56. Dobson J, Mcbain SC, Griesenbach U et al. Magnetic nanoparticles as gene delivery agents: enhanced transfection in the presence of oscillating magnet arrays. Nanotechnology 19(40), (2008).
57. Flick E, Belski A, Li WZ, Steinhoff G, Gatzen HH. Magnetic microactuator for controlling nanoparticles in gene delivery applications. IEEE Trans. Magn. 45(10), 4869-4872 (2009).
58. Ramanujana RV, Ang D, Nguyen QV, Kayal S, Preiser PR, Rawat RS. Insights into the mechanism of magnetic particle assisted gene delivery. Acta Biomaterialia. 7(3), 1319-1326 (2011).
59. Maherani B, Ara-Tehrany E, Mozafari RM, Gaiani C, Linder M. Liposomes: a review of manufacturing techniques and targeting strategies. Curr. Pharm. Biotech. 7(3), 436-452 (417) (2011).
60. Felgner PL, Gadek TR, Holm M et al. Lipofection. A highly efficient, lipid-mediated DNA-transfection procedure. Proc. Natl Acad. Sci. USA 84(21), 7413-7417 (1987).
61. Zuhorn IS, Engberts JB, Hoekstra D. Gene delivery by cationic lipid vectors. overcoming cellular barriers. Eur. Biophys. J. 36(4-5), 349-362 (2007).
62. Rao NM, Gopal V. Cell biological and biophysical aspects of lipid-mediated gene delivery. Biosci. Rep. 26(4), 301-324 (2006).
63. Fiszer-Kierzkowska A, Vydra N, Wysocka- Wycisk A et al. Liposome-based DNA carriers may induce cellular stress response and change gene expression pattern in transfected cells. BMC Mol. Biol. 12(1), 27 (2011).
64. Mykhaylyk O, Sanchez-Antequera Y, Vlaskou D et al. Liposomal magnetofection. Methods Mol. Biol. 605, 487-525 (2010).
65. Pan X, Guan J, Yoo JW, Epstein AJ, Lee LJ, Lee RJ. Cationic lipid-coated magnetic nanoparticles associated with transferrin for gene delivery. Int. J. Pharm. 358(1-2), 263-270 (2008).
66. Xenariou S, Griesenbach U, Ferrari S et al. Using magnetic forces to enhance non-viral gene transfer to airway epithelium in vivo. Gene Ther. 13(21), 1545-1552 (2006).
67. Yang SY, Sun JS, Liu CH et al. Ex vivo magnetofection with magnetic nanoparticles: a novel platform for nonviral tissue engineering. Artif. Organs 32(3), 195-204 (2008).
68. Zheng X, Lu J, Deng L, Xiong Y, Chen J. Preparation and characterization of magnetic cationic liposome in gene delivery. Int. J. Pharm. 366(1-2), 211-217 (2009).
69. Holzbach T, Vlaskou D, Neshkova I et al. Non-viral VEGF(165) gene therapy- magnetofection of acoustically active magnetic lipospheres ('magnetobubbles') increases tissue survival in an oversized skin flap model. J. Cell. Mol. Med. 14(3), 587-599 (2008).
70. de Bruin K, Ruthardt N, von Gersdorff K et al. Cellular dynamics of EGF receptor-targeted synthetic viruses. Mol. Ther. 15(7), 1297-1305 (2007).
71. Ou L, Li W, Liu Y et al. Animal models of cardiac disease and stem cell therapy. Open Cardiovasc. Med. J. 4, 231-239 (2011).
72. Ou L, Li W, Zhang Y et al. Intracardiac injection of matrigel induces stem cell recruitment and improves cardiac functions in a rat myocardial infarction model. J. Cell. Mol. Med. 15(6), 1310-1318 (2010).
73. Nesselmann C, Li W, Ma N, Steinhoff G. Stem cell-mediated neovascularization in heart repair. Ther. Adv. Cardiovasc. Dis. 4(1), 27-42 (2010).
74. Klopsch C, Furlani D, Gabel R et al. Intracardiac injection of erythropoietin induces stem cell recruitment and improves cardiac functions in a rat myocardial infarction model. J. Cell. Mol. Med. 13(4), 664-679 (2009).
75. Shen J, Fu X, Ou L et al. Construction of ureteral grafts by seeding urothelial cells and bone marrow mesenchymal stem cells into polycaprolactone-lecithin electrospun fibers. Int. J. Artif. Organs 33(3), 161-170 (2010).
76. Ferreira L, Karp JM, Nobre L, Langer R. New opportunities. The use of nanotechnologies to manipulate and track stem cells. Cell Stem Cell 3(2), 136-146 (2008).
77. Gaebel R, Furlani D, Sorg H et al. Cell origin of human mesenchymal stem cells determines a different healing performance in cardiac regeneration. PLoS ONE 6(2), e15652 (2011).
78. Furlani D, Li W, Pittermann E et al. A transformed cell population derived from cultured mesenchymal stem cells has no functional effect after transplantation into the injured heart. Cell Transplant 18(3), 319-331 (2009).
79. Zhou YF, Bosch-Marce M, Okuyama H et al. Spontaneous transformation of cultured mouse bone marrow-derived stromal cells. Cancer Res. 66(22), 10849-10854 (2006).
80. Vector technology and cell targeting: peptide-tagged adenoviral vectors as a powerful tool for cell specific targeting. In: Regenerative Medicine: From Protocol to Patient. Steinhoff G (Ed.).Springer, NY, USA 1032 (2011).
81. Clements MO, Godfrey A, Crossley J, Wilson SJ, Takeuchi Y, Boshoff C. Lentiviral manipulation of gene expression in human adult and embryonic stem cells. Tissue Eng. 12(7), 1741-1751 (2006).
82. Santos JL, Pandita D, Rodrigues J, Pego AP, Granja PL, Tomas H. Nonviral gene delivery to mesenchymal stem cells. Methods, strategies and application in bone tissue engineering and regeneration. Curr. Gene Ther. 11(1), 46-57 (2011).
83. Lee CH, Kim EY, Jeon K et al. Simple, efficient, and reproducible gene transfection of mouse embryonic stem cells by magnetofection. Stem Cells Dev. 17(1), 133-141 (2008).
84. Pickard M, Chari D. Enhancement of magnetic nanoparticle-mediated gene transfer to astrocytes by 'magnetofection': effects of static and oscillating fields. Nanomedicine (Lond.) 5(2), 217-232 (2010).
85. Pickard MR, Barraud P, Chari DM. The transfection of multipotent neural precursor/ stem cell transplant populations with magnetic nanoparticles. Biomaterials 32(9), 2274-2284 (2011).
86. + cells. Tissue Eng. Part C Methods 16(5), 1069-1081 (2010).
87. Antequera YS, Cengizeroglu A, Hammerschmid E, Mykhaylyk O, Plank C. Magselectofection-combined magnetic cell separation and magnetofection. A novel nonviral and viral technology for ex vivo gene therapy. Hum. Gene Ther. 19(10), 1145-1146 (2008).
88. Sanchez-Antequera Y, Cengizeroglu A, Kopera A et al. A novel nonviral and viral technology for ex vivo gene therapy. Magselectofection. Hum. Gene Ther. 20(11), 1411-1411 (2009).
89. Sanchez-Antequera Y, Mykhaylyk O, Van Til NP et al. Magselectofection: an integrated method of nanomagnetic separation and genetic modification of target cells. Blood 117(16), E171-E181 (2011).